HCA HCA Healthcare, Inc. Common Stock
À propos de HCA Healthcare, Inc. Common Stock Présentation de l'entreprise depuis Wikipedia
Hospital Corporation of America, ou HCA est le plus grand groupe hospitalier privé au monde.
Lire la suite
Hospital Corporation of America, ou HCA est le plus grand groupe hospitalier privé au monde.
Histoire
HCA est fondé en 1968 par des membres de la famille Frist, Thomas Frist et son fils Thomas Jr Frist.
En octobre 2014, HCA annonce l'acquisition de CareNow, une entreprise de services d'urgence au Texas pour environ 1 milliard de dollars.
En août 2018, HCA annonce l'acquisition de Mission Health, une organisation hospitalière basée en Caroline du Nord, pour 1,5 milliard de dollars.
Activité
Basé à Nashville, dans le Tennessee, il est considéré comme le principal facteur qui fait de cette ville un point névralgique en matière de soins de santé. Le groupe gère 273 établissements de soins intensifs, centres chirurgicaux, hôpitaux psychiatriques et maisons de convalescence dans une vingtaine d'États. Il possède également des cliniques en Suisse et en Grande-Bretagne.
HCA a réalisé en 2005 un chiffre d'affaires de 24,5 milliards de dollars et un bénéfice de 1,4 milliard. En 2018, elle enregistre un chiffre d'affaires de 46,6 milliards de dollars pour un résultat net porté à 3,78 milliards.
Direction et actionnariat
Le chef de la majorité républicaine au sénat américain et fils de Thomas Frist, Bill Frist, possède des parts dans la compagnie. La majeure partie de sa fortune, estimée à plus ou moins 20 millions de dollars, est le fruit de sa participation dans le HCA. Jack O. Bovender, Jr., est quant à lui directeur général de HCA. Il est diplômé de l'université Duke.
Source : Wikipedia, CC BY-SA 4.0 · Voir sur Wikipedia ↗
HCA Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
HCA Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Dividendes Rendement, ratio de distribution, historique des dividendes, CAGR à 5 ans
| Date ex-dividende | Montant |
|---|---|
| 16 juin 2026 | $0,7800 |
| 17 mars 2026 | $0,7800 |
| 15 décembre 2025 | $0,7200 |
| 16 septembre 2025 | $0,7200 |
| 16 juin 2025 | $0,7200 |
| 17 mars 2025 | $0,7200 |
| 13 décembre 2024 | $0,6600 |
| 16 septembre 2024 | $0,6600 |
| 14 juin 2024 | $0,6600 |
| 14 mars 2024 | $0,6600 |
| 13 décembre 2023 | $0,6000 |
| 14 septembre 2023 | $0,6000 |
| 15 juin 2023 | $0,6000 |
| 16 mars 2023 | $0,6000 |
| 13 décembre 2022 | $0,5600 |
| 15 septembre 2022 | $0,5600 |
| 15 juin 2022 | $0,5600 |
| 16 mars 2022 | $0,5600 |
| 13 décembre 2021 | $0,4800 |
| 15 septembre 2021 | $0,4800 |
HCA Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
- Achat fort 6 20,0%
- Achat 11 36,7%
- Conserver 12 40,0%
- Vente 1 3,3%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
21 analystes · 2026-08-17Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 30 juin 2026 | $7.62 | $7.54 | 0.08% |
| 31 mars 2026 | $7.15 | $7.21 | -0.06% |
| 31 décembre 2025 | $8.14 | $7.53 | 0.61% |
| 30 septembre 2025 | $6.96 | $5.77 | 1.2% |
| 30 juin 2025 | $6.83 | $6.31 | 0.52% |
| 31 mars 2025 | $6.45 | $5.84 | 0.61% |
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| HCA | $104.86B | 16.5 | 7.1% | 9.0% | -159.1% | — |
| THC | $17.28B | 12.8 | 3.1% | 11.1% | 56.4% | — |
| EHC | $10.61B | 19.2 | 10.5% | 9.5% | 25.1% | — |
| ENSG | $10.12B | 29.8 | 18.7% | 6.8% | 16.9% | — |
| UHS | — | 9.4 | 9.7% | 8.6% | 21.4% | — |
| PACS | $6.01B | 31.5 | 29.3% | 3.6% | 23.1% | — |
| CON | $2.53B | 15.1 | 13.9% | 7.7% | 49.8% | — |
| BKD | $2.57B | -9.6 | 2.2% | -8.2% | -313.2% | 26.2% |
| ACHC | $1.28B | -1.2 | 5.0% | -33.3% | -43.9% | — |
| SNDA | $612M | -7.7 | 25.2% | -18.6% | -197.2% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 12
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $75.60B | $70.60B | $64.97B | $60.23B | $58.75B | $51.53B | $51.34B | $46.68B | $43.61B | $41.49B | |
| SG&A Expense | $548M | $421M | $353M | $307M | $337M | $416M | $370M | $344M | $340M | $343M | |
| Operating Expenses | $65.77B | $62.08B | $57.26B | $51.65B | $48.92B | $46.10B | $46.09B | $41.34B | $39.23B | $36.68B | |
| Interest Expense | $2.25B | $2.06B | $1.94B | $1.74B | $1.57B | $1.58B | $1.82B | $1.75B | $1.69B | $1.71B | |
| Pretax Income | $9.83B | $8.52B | $7.71B | $8.58B | $9.83B | $5.43B | $5.24B | $5.33B | $4.38B | $4.81B | |
| Income Tax | $2.05B | $1.87B | $1.61B | $1.75B | $2.11B | $1.04B | $1.10B | $946M | $1.64B | $1.38B | |
| Net Income | $6.78B | $5.76B | $5.24B | $5.64B | $6.96B | $3.75B | $3.50B | $3.79B | $2.22B | $2.89B | |
| EPS (Basic) | $28.70 | $22.27 | $19.25 | $19.43 | $21.52 | $11.10 | $10.27 | $10.90 | $6.12 | $7.53 | |
| EPS (Diluted) | $28.33 | $22.00 | $18.97 | $19.15 | $21.16 | $10.93 | $10.07 | $10.66 | $5.95 | $7.30 | |
| Shares (Basic) | 236,413,000 | 258,603,000 | 272,404,000 | 290,348,000 | 323,315,000 | 338,274,000 | 341,210,000 | 347,297,000 | 362,305,000 | 383,591,000 | |
| Shares (Diluted) | 239,495,000 | 261,806,000 | 276,412,000 | 294,666,000 | 328,752,000 | 343,605,000 | 348,226,000 | 355,303,000 | 372,221,000 | 395,851,000 | |
| EBITDA | $3.52B | $3.31B | $3.08B | $2.97B | $2.85B | $2.72B | $2.60B | $2.28B | $2.13B | $1.97B |
Bilan 22
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.04B | $1.93B | $935M | $908M | $1.45B | $1.79B | $621M | $502M | $732M | $646M | |
| Short-term Investments | · | · | · | · | · | $116M | $147M | $47M | $54M | $49M | |
| Receivables | $10.87B | $10.75B | $9.96B | $8.89B | $8.10B | $7.05B | $7.38B | $6.79B | $6.50B | $5.83B | |
| Inventory | $1.65B | $1.74B | $2.02B | $2.07B | $1.99B | $2.02B | $1.85B | $1.73B | $1.57B | $1.50B | |
| Other Current Assets | $2.22B | $1.99B | $2.01B | $1.78B | $2.01B | $1.46B | $1.35B | $1.19B | $1.17B | $1.11B | |
| Current Assets | $15.78B | $16.41B | $14.93B | $13.64B | $13.54B | $12.33B | $11.20B | $10.21B | $9.98B | $9.09B | |
| PP&E (Net) | $31.14B | $29.41B | $27.71B | $25.57B | $24.06B | $23.20B | $22.71B | $19.76B | $17.89B | $16.35B | |
| PP&E (Gross) | $66.28B | $62.51B | $58.55B | $54.76B | $51.35B | $49.32B | $47.23B | $42.97B | $40.08B | $37.05B | |
| Accum. Depreciation | $35.13B | $33.10B | $30.83B | $29.18B | $27.29B | $26.12B | $24.52B | $23.21B | $22.19B | $20.70B | |
| Other Non-current Assets | $255M | $230M | $184M | $298M | $598M | $546M | $480M | $690M | $710M | $1.07B | |
| Total Assets | $60.72B | $59.51B | $56.21B | $52.44B | $50.74B | $47.49B | $45.06B | $39.21B | $36.59B | $33.76B | |
| Accounts Payable | $4.66B | $4.28B | $4.23B | $4.24B | $4.11B | $3.54B | $2.90B | $2.58B | $2.61B | $2.32B | |
| Current Liabilities | $16.35B | $15.18B | $12.65B | $9.90B | $9.58B | $8.70B | $7.76B | $7.57B | $6.16B | $5.83B | |
| Capital Leases | $1.85B | $1.86B | $1.90B | $1.75B | $1.75B | $1.67B | $1.50B | · | · | · | |
| Total Liabilities | · | · | · | · | · | · | $45.62B | $42.12B | $41.59B | $39.39B | |
| Long-term Debt | $44.28B | $43.03B | $39.59B | $38.08B | $34.58B | $31.00B | $33.72B | $32.82B | $33.06B | $31.38B | |
| Total Debt | $41.60B | $43.03B | $39.59B | $38.08B | $34.58B | $31.00B | $33.72B | $32.82B | $33.06B | $31.38B | |
| Retained Earnings | $-5.72B | $-2.12B | $-1.35B | $-2.28B | $-532M | $777M | $-2.35B | $-4.57B | $-6.53B | $-6.97B | |
| AOCI | $-305M | $-387M | $-425M | $-490M | $-404M | $-502M | $-460M | $-381M | $-278M | $-338M | |
| Stockholders' Equity | $-6.03B | $-2.50B | $-1.77B | $-2.77B | $-933M | $572M | $-2.81B | $-4.95B | $-6.81B | $-7.30B | |
| Liabilities + Equity | $60.72B | $59.51B | $56.21B | $52.44B | $50.74B | $47.49B | $45.06B | $39.21B | $36.59B | $33.76B | |
| Shares Outstanding | 224,605,100 | 249,981,400 | 265,537,300 | 277,378,300 | 305,476,800 | 339,425,600 | 338,445,600 | 342,895,200 | 350,091,600 | 370,535,900 |
Flux de trésorerie 17
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3.52B | $3.31B | $3.08B | $2.97B | $2.85B | $2.72B | $2.60B | $2.28B | $2.13B | $1.97B | |
| Stock-based Comp | $401M | $360M | $262M | $341M | $440M | $362M | $347M | $268M | $270M | $251M | |
| Amort. of Intangibles | $12M | $16M | $20M | $44M | $25M | $26M | · | · | · | · | |
| Other Non-cash | $1.93B | $1.08B | $850M | $-431M | $-1.29B | $2.40B | $1.07B | $461M | $-3.53B | $-2.67B | |
| Operating Cash Flow | $12.64B | $10.51B | $9.43B | $8.52B | $8.96B | $9.23B | $7.60B | $6.76B | $5.43B | $5.65B | |
| CapEx | $4.94B | $4.88B | $4.74B | $4.39B | $3.58B | $2.83B | $4.16B | $3.57B | $3.02B | $2.76B | |
| Investing Cash Flow | $-4.99B | $-4.93B | $-5.32B | $-3.39B | $-2.64B | $-3.39B | $-5.72B | $-3.90B | $-4.28B | $-3.24B | |
| Debt Issued | $8.47B | $7.50B | $3.22B | $6.00B | $4.34B | $2.70B | $6.45B | $2.00B | $1.50B | $5.40B | |
| Net Debt Issued | $1.08B | $5.08B | $2.31B | $3.17B | $475M | $-737M | $1.13B | $296M | $749M | $925M | |
| Stock Repurchased | $10.07B | $6.04B | $3.81B | $7.00B | $8.21B | $441M | $1.03B | $1.53B | $2.05B | $2.75B | |
| Net Stock Activity | $-10.07B | $-6.04B | $-3.81B | $-7.00B | $-8.21B | $-441M | $-1.03B | $-1.53B | $-2.05B | $-2.75B | |
| Dividends Paid | $679M | $690M | $661M | $653M | $624M | $153M | $550M | $487M | $0 | · | |
| Financing Cash Flow | $-8.55B | $-4.58B | $-4.09B | $-5.66B | $-6.66B | $-4.68B | $-1.77B | $-3.08B | $-1.06B | $-2.51B | |
| Net Change in Cash | $-893M | $998M | $27M | $-543M | $-342M | $1.17B | $119M | $-230M | $86M | $-95M | |
| Taxes Paid | $1.74B | $1.84B | $1.39B | $1.18B | $2.18B | $1.00B | $849M | $872M | $1.21B | $1.25B | |
| Free Cash Flow | $7.69B | $5.64B | $4.69B | $4.13B | $5.38B | $6.40B | $3.44B | $3.19B | $2.41B | $2.89B | |
| Levered FCF | $5.91B | $4.03B | $3.16B | $2.74B | $4.15B | $5.12B | $2.00B | $1.74B | $1.35B | $1.68B |
Rentabilité 5
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 9.0% | 8.2% | 8.1% | 9.4% | 11.8% | 7.3% | 6.8% | 8.1% | · | · | |
| Pretax Margin | 13.0% | 12.1% | 11.9% | 14.2% | 16.7% | 10.5% | 10.2% | 11.4% | · | · | |
| EBITDA Margin | 4.7% | 4.7% | 4.7% | 4.9% | 4.9% | 5.3% | 5.1% | 4.9% | · | · | |
| ROA | 11.3% | 10.0% | 9.7% | 10.9% | 14.2% | 8.1% | 8.3% | 10.0% | 6.3% | 8.7% | |
| ROE | -159.1% | -269.6% | -230.9% | -305.0% | -3853.7% | -335.8% | -90.4% | -64.4% | -31.4% | -38.8% |
Liquidité et Solvabilité 4
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.0 | 1.1 | 1.2 | 1.4 | 1.4 | 1.4 | 1.4 | 1.3 | 1.6 | 1.6 | |
| Quick Ratio | 0.7 | 0.8 | 0.9 | 1.0 | 1.0 | 1.0 | 1.1 | 1.0 | 1.2 | 1.1 | |
| Debt / Equity | -6.9 | -17.2 | -22.3 | -13.8 | -37.1 | 54.2 | -12.0 | -6.6 | -4.9 | -4.3 | |
| LT Debt / Equity | -6.9 | -15.3 | -21.0 | -13.6 | -36.8 | 53.8 | -12.0 | -6.5 | -4.8 | -4.3 |
Efficacité 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.3 | 1.2 | 1.2 | 1.2 | 1.2 | 1.1 | 1.2 | 1.2 | · | · | |
| Receivables Turnover | 7.0 | 6.8 | 6.9 | 7.1 | 7.8 | 7.1 | 7.2 | 7.0 | · | · |
Taux de croissance 10
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 7.1% | 8.7% | 7.9% | 2.5% | 14.0% | · | · | · | · | · | |
| Revenue CAGR 3Y | 7.9% | 6.3% | 8.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 8.0% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 28.8% | 16.0% | -0.94% | -9.5% | 93.6% | · | · | · | · | · | |
| EPS CAGR 3Y | 13.9% | 1.3% | 20.2% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 21.0% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 17.8% | 9.9% | -7.1% | -18.9% | 85.3% | · | · | · | · | · | |
| Net Income CAGR 3Y | 6.3% | -6.1% | 11.8% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 12.6% | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 34.7% | · | · | · | · | · | · | · | · | · |
Valorisation (TTM) 17
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $75.60B | $70.60B | $64.97B | $60.23B | $58.75B | $51.53B | $51.34B | $46.68B | $43.61B | $41.49B | |
| Net Income TTM | $6.78B | $5.76B | $5.24B | $5.64B | $6.96B | $3.75B | $3.50B | $3.79B | $2.22B | $2.89B | |
| Market Cap | $104.86B | $75.03B | $71.88B | $66.56B | $78.48B | $55.82B | $50.03B | $42.67B | $30.75B | $27.43B | |
| Enterprise Value | $145.42B | $116.13B | $110.53B | $103.74B | $111.61B | $84.92B | $82.98B | $74.95B | $63.02B | $58.11B | |
| P/E | 16.5 | 13.6 | 14.3 | 12.5 | 12.1 | 15.0 | 14.7 | 11.7 | 14.8 | 10.1 | |
| P/S | 1.4 | 1.1 | 1.1 | 1.1 | 1.3 | 1.1 | 1.0 | 0.9 | 0.7 | 0.7 | |
| P/B | -17.4 | -30.0 | -40.5 | -24.1 | -84.1 | 97.6 | -17.8 | -8.6 | -4.5 | -3.8 | |
| P / Tangible Book | · | · | · | · | · | 97.6 | · | · | · | · | |
| P / Cash Flow | 8.3 | 7.1 | 7.6 | 7.8 | 8.8 | 6.0 | 6.6 | 6.3 | 5.7 | 4.9 | |
| P / FCF | 13.6 | 13.3 | 15.3 | 16.1 | 14.6 | 8.7 | 14.5 | 13.4 | 12.8 | 9.5 | |
| EV / EBITDA | 41.3 | 35.1 | 35.9 | 34.9 | 39.1 | 31.2 | 32.0 | 32.9 | 29.6 | 29.6 | |
| EV / FCF | 18.9 | 20.6 | 23.6 | 25.1 | 20.7 | 13.3 | 24.1 | 23.5 | 26.1 | 20.1 | |
| EV / Revenue | 1.9 | 1.6 | 1.7 | 1.7 | 1.9 | 1.6 | 1.6 | 1.6 | 1.4 | 1.4 | |
| Dividend Yield | 0.65% | 0.92% | 0.92% | 0.98% | 0.80% | 0.27% | 1.1% | 1.1% | 0.00% | · | |
| Earnings Yield | 6.1% | 7.3% | 7.0% | 8.0% | 8.2% | 6.7% | 6.8% | 8.6% | 6.8% | 9.9% | |
| Payout Ratio | 10.0% | 12.0% | 12.6% | 11.6% | 9.0% | 4.1% | 15.7% | 12.9% | · | · | |
| Annual Payout | $679M | $690M | $661M | $653M | $624M | $153M | $550M | $487M | $0 | · |
Compte de résultat 12
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $20.23B | $19.11B | $19.51B | $19.16B | $18.61B | $18.32B | $18.29B | $17.49B | $17.49B | $17.34B | $17.30B | $16.21B | $15.86B | $15.59B | $15.50B | $14.97B | |
| SG&A Expense | $148M | $133M | $153M | $139M | $130M | $126M | $120M | $111M | $100M | $90M | $108M | $89M | $82M | $74M | $79M | $74M | |
| Operating Expenses | $17.74B | $16.82B | $16.84B | $16.74B | $16.19B | $15.99B | $16.15B | $15.58B | $15.26B | $15.09B | $14.96B | $14.58B | $14.05B | $13.67B | $12.20B | $13.27B | |
| Interest Expense | $599M | $584M | $572M | $561M | $568M | $547M | $528M | $515M | $506M | $512M | $491M | $483M | $485M | $479M | $453M | $446M | |
| Pretax Income | $2.49B | $2.29B | $2.67B | $2.42B | $2.42B | $2.33B | $2.13B | $1.91B | $2.24B | $2.25B | $2.35B | $1.63B | $1.81B | $1.92B | $3.30B | $1.70B | |
| Income Tax | $564M | $430M | $509M | $515M | $524M | $502M | $447M | $424M | $550M | $445M | $484M | $355M | $397M | $379M | $656M | $360M | |
| Net Income | $1.70B | $1.62B | $1.88B | $1.64B | $1.65B | $1.61B | $1.44B | $1.27B | $1.46B | $1.59B | $1.61B | $1.08B | $1.19B | $1.36B | $2.08B | $1.13B | |
| EPS (Basic) | $7.70 | $7.25 | $8.22 | $7.05 | $6.91 | $6.52 | $5.72 | $4.94 | $5.60 | $6.01 | $6.00 | $3.98 | $4.35 | $4.92 | $7.30 | $3.97 | |
| EPS (Diluted) | $7.62 | $7.15 | $8.09 | $6.96 | $6.83 | $6.45 | $5.66 | $4.88 | $5.53 | $5.93 | $5.92 | $3.91 | $4.29 | $4.85 | $7.20 | $3.91 | |
| Shares (Basic) | 220,538,000 | 223,588,000 | -482,587,000 | 232,891,000 | 239,173,000 | 246,936,000 | -523,751,000 | 256,763,000 | 261,156,000 | 264,435,000 | -550,173,000 | 271,173,000 | 274,494,000 | 276,910,000 | -590,583,000 | 285,958,000 | |
| Shares (Diluted) | 222,828,000 | 226,652,000 | -488,037,000 | 236,181,000 | 241,911,000 | 249,440,000 | -530,198,000 | 259,917,000 | 264,071,000 | 268,016,000 | -558,171,000 | 275,424,000 | 278,198,000 | 280,961,000 | -598,621,000 | 289,852,000 | |
| EBITDA | $944M | $930M | · | $889M | $863M | $860M | · | $842M | $819M | $795M | · | $769M | $763M | $756M | · | $749M |
Bilan 20
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.01B | $940M | $1.04B | $997M | $939M | $1.06B | $1.93B | $2.89B | $831M | $1.28B | · | $891M | $862M | $842M | · | $999M | |
| Receivables | $12.28B | $11.32B | $10.87B | $10.43B | $10.46B | $11.09B | $10.75B | $9.91B | $10.24B | $10.04B | · | $9.18B | $8.71B | $8.66B | · | $8.55B | |
| Inventory | $1.66B | $1.68B | $1.65B | $1.73B | $1.79B | $1.79B | $1.74B | $1.78B | $1.80B | $1.90B | · | $2.03B | $2.05B | $2.08B | · | $2.01B | |
| Other Current Assets | $2.23B | $2.11B | $2.22B | $2.13B | $2.37B | $2.32B | $1.99B | $2.08B | $2.30B | $2.05B | · | $2.19B | $2.26B | $1.96B | · | $1.92B | |
| Current Assets | $17.19B | $16.05B | $15.78B | $15.29B | $15.56B | $16.26B | $16.41B | $16.66B | $15.17B | $15.28B | · | $14.29B | $13.89B | $13.54B | · | $13.48B | |
| PP&E (Net) | $31.82B | $31.47B | $31.14B | $30.57B | $30.12B | $29.74B | $29.41B | $29.05B | $28.64B | $28.10B | · | $27.12B | $26.64B | $26.05B | · | $24.98B | |
| PP&E (Gross) | $68.41B | $67.36B | $66.28B | $65.49B | $64.39B | $63.68B | $62.51B | $61.75B | $60.62B | $59.44B | · | $57.77B | $56.67B | $55.46B | · | $53.73B | |
| Accum. Depreciation | $36.59B | $35.89B | $35.13B | $34.92B | $34.27B | $33.94B | $33.10B | $32.70B | $31.99B | $31.34B | · | $30.66B | $30.02B | $29.41B | · | $28.75B | |
| Other Non-current Assets | $258M | $326M | $255M | $277M | $236M | $226M | $230M | $309M | $240M | $199M | · | $200M | $196M | $319M | · | $461M | |
| Total Assets | $63.25B | $61.45B | $60.72B | $59.75B | $59.54B | $59.80B | $59.51B | $59.46B | $57.38B | $56.96B | $56.21B | $54.59B | $53.59B | $52.71B | $52.44B | $51.48B | |
| Accounts Payable | $4.75B | $4.81B | $4.66B | $4.55B | $4.25B | $4.49B | $4.28B | $4.24B | $4.03B | $4.74B | · | $4.14B | $3.82B | $3.77B | · | $4.16B | |
| Current Liabilities | $17.31B | $19.26B | $16.35B | $17.90B | $15.94B | $13.63B | $15.18B | $14.90B | $14.30B | $13.14B | · | $12.41B | $11.54B | $11.03B | · | $9.78B | |
| Capital Leases | $1.83B | $1.82B | $1.85B | $1.84B | $1.88B | $1.86B | $1.86B | $1.92B | $1.89B | $1.91B | · | $1.78B | $1.81B | $1.72B | · | $1.76B | |
| Long-term Debt | $45.83B | $44.37B | $44.28B | $42.60B | $42.70B | $44.58B | $43.03B | $42.97B | $40.88B | $40.19B | · | $39.35B | $38.93B | $38.86B | · | $37.71B | |
| Total Debt | $43.45B | $39.49B | · | $38.40B | $39.38B | $44.58B | · | $42.97B | $40.88B | $40.19B | · | $39.35B | $38.93B | $38.86B | · | $37.71B | |
| Retained Earnings | $-6.31B | $-5.98B | $-5.72B | $-5.02B | $-4.09B | $-3.16B | $-2.12B | $-1.81B | $-1.17B | $-1.19B | · | $-1.99B | $-1.85B | $-2.03B | · | $-2.78B | |
| AOCI | $-334M | $-327M | $-305M | $-317M | $-309M | $-357M | $-387M | $-378M | $-433M | $-433M | $-425M | $-491M | $-456M | $-470M | $-490M | $-592M | |
| Stockholders' Equity | $-6.64B | $-6.30B | $-6.03B | $-5.33B | $-4.39B | $-3.52B | $-2.50B | $-2.18B | $-1.60B | $-1.61B | · | $-2.48B | $-2.30B | $-2.50B | · | $-3.37B | |
| Liabilities + Equity | $63.25B | $61.45B | $60.72B | $59.75B | $59.54B | $59.80B | $59.51B | $59.46B | $57.38B | $56.96B | · | $54.59B | $53.59B | $52.71B | · | $51.48B | |
| Shares Outstanding | 217,963,300 | 222,530,900 | 224,605,100 | 229,845,100 | 236,143,900 | 242,955,400 | 249,981,400 | 254,517,700 | 259,237,600 | 263,215,800 | · | 268,967,300 | 272,931,700 | 275,939,900 | · | 283,903,500 |
Flux de trésorerie 16
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $944M | $930M | $911M | $889M | $863M | $860M | $856M | $842M | $819M | $795M | $789M | $769M | $763M | $756M | $750M | $749M | |
| Stock-based Comp | $85M | $86M | $100M | $104M | $99M | $98M | $85M | $76M | $112M | $87M | $57M | $72M | $56M | $77M | $83M | $87M | |
| Other Non-cash | · | $-622M | · | · | · | $-917M | · | · | · | $-4M | · | · | · | $-393M | · | · | |
| Operating Cash Flow | $2.33B | $2.01B | $2.36B | $4.42B | $4.21B | $1.65B | $2.56B | $3.52B | $1.97B | $2.47B | $2.67B | $2.48B | $2.48B | $1.80B | $2.53B | $3.02B | |
| CapEx | $1.23B | $1.12B | $1.49B | $1.29B | $1.18B | $991M | $1.28B | $1.19B | $1.28B | $1.12B | $1.16B | $1.15B | $1.24B | $1.20B | $1.32B | $1.13B | |
| Investing Cash Flow | $-1.56B | $-1.28B | $-1.32B | $-1.39B | $-1.25B | $-1.03B | $-1.35B | $-1.35B | $-1.33B | $-903M | $-1.60B | $-1.31B | $-1.26B | $-1.15B | $-793M | $-546M | |
| Debt Issued | $2.99B | $0 | $3.24B | $0 | $0 | $5.23B | $0 | $3.01B | $0 | $4.48B | $4M | $2M | $3.22B | $0 | $21M | $10M | |
| Net Debt Issued | · | $-58M | · | · | · | $1.34B | · | · | · | $2.42B | · | · | · | $-550M | · | · | |
| Stock Repurchased | $2.06B | $1.57B | $2.56B | $2.50B | $2.50B | $2.51B | $1.70B | $1.79B | $1.37B | $1.18B | $910M | $1.14B | $915M | $846M | $1.52B | $698M | |
| Net Stock Activity | · | $-1.57B | · | · | · | $-2.51B | · | · | · | $-1.18B | · | · | · | $-846M | · | · | |
| Dividends Paid | $171M | $183M | $162M | $166M | $171M | $180M | $165M | $169M | $171M | $185M | $160M | $162M | $164M | $175M | $156M | $160M | |
| Financing Cash Flow | $-704M | $-830M | $-999M | $-2.97B | $-3.09B | $-1.50B | $-2.16B | $-110M | $-1.09B | $-1.22B | $-1.04B | $-1.13B | $-1.20B | $-725M | $-1.84B | $-2.32B | |
| Net Change in Cash | $73M | $-100M | $43M | $58M | $-121M | $-873M | $-955M | $2.06B | $-453M | $349M | $44M | $29M | $20M | $-66M | $-91M | $141M | |
| Taxes Paid | $730M | $-5M | $1.51B | $81M | $136M | $10M | $358M | $487M | $998M | $1M | $316M | $297M | $766M | $7M | $244M | $322M | |
| Free Cash Flow | · | $895M | · | · | · | $660M | · | · | · | $1.35B | · | · | · | $606M | · | · | |
| Levered FCF | · | $421M | · | · | · | $231M | · | · | · | $940M | · | · | · | $221M | · | · |
Rentabilité 5
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 8.4% | 8.5% | · | 8.6% | 8.9% | 8.8% | · | 7.3% | 8.3% | 9.2% | · | 6.7% | 7.5% | 8.7% | · | 7.6% | |
| Pretax Margin | 12.3% | 12.0% | · | 12.6% | 13.0% | 12.7% | · | 10.9% | 12.8% | 13.0% | · | 10.1% | 11.4% | 12.3% | · | 11.4% | |
| EBITDA Margin | 4.7% | 4.9% | · | 4.6% | 4.6% | 4.7% | · | 4.8% | 4.7% | 4.6% | · | 4.7% | 4.8% | 4.9% | · | 5.0% | |
| ROA | 2.8% | 2.7% | · | 2.8% | 2.8% | 2.8% | · | 2.2% | 2.6% | 2.9% | · | 2.0% | 2.3% | 2.6% | · | 2.2% | |
| ROE | -30.8% | -33.0% | · | -43.7% | -55.2% | -62.7% | · | -54.5% | -74.9% | -77.4% | · | -36.9% | -39.9% | -60.2% | · | -55.8% |
Liquidité et Solvabilité 4
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.0 | 0.8 | · | 0.9 | 1.0 | 1.2 | · | 1.1 | 1.1 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.4 | |
| Quick Ratio | 0.8 | 0.6 | · | 0.6 | 0.7 | 0.9 | · | 0.9 | 0.8 | 0.9 | · | 0.8 | 0.8 | 0.9 | · | 1.0 | |
| Debt / Equity | -6.5 | -6.3 | · | -7.2 | -9.0 | -12.7 | · | -19.7 | -25.6 | -24.9 | · | -15.9 | -16.9 | -15.6 | · | -11.2 | |
| LT Debt / Equity | -6.5 | -6.3 | · | -7.2 | -9.0 | -11.7 | · | -17.5 | -22.7 | -23.0 | · | -14.9 | -15.9 | -14.6 | · | -11.1 |
Efficacité 2
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Receivables Turnover | 1.8 | 1.7 | · | 1.9 | 1.8 | 1.7 | · | 1.8 | 1.8 | 1.9 | · | 1.8 | 1.8 | 1.8 | · | 1.8 |
Valorisation (TTM) 14
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $77.11B | $75.20B | · | $73.57B | $71.91B | $70.64B | · | $68.53B | $66.91B | $65.00B | · | $62.64B | $61.24B | $60.33B | · | $60.01B | |
| Net Income TTM | $6.62B | $6.53B | · | $6.18B | $5.99B | $5.93B | · | $5.40B | $5.32B | $5.23B | · | $4.77B | $4.84B | $4.92B | · | $5.83B | |
| Market Cap | $84.98B | $105.31B | · | $97.96B | $90.47B | $83.95B | · | $103.44B | $83.29B | $87.79B | · | $66.16B | $82.83B | $72.76B | · | $52.18B | |
| Enterprise Value | $127.42B | $143.86B | · | $135.36B | $128.91B | $127.47B | · | $143.52B | $123.34B | $126.70B | · | $104.62B | $120.90B | $110.77B | · | $88.89B | |
| P/E | 13.7 | 17.3 | · | 17.0 | 16.2 | 15.2 | · | 20.1 | 16.3 | 17.6 | · | 14.5 | 17.9 | 15.7 | · | 9.7 | |
| P/S | 1.1 | 1.4 | · | 1.3 | 1.3 | 1.2 | · | 1.5 | 1.2 | 1.4 | · | 1.1 | 1.4 | 1.2 | · | 0.9 | |
| P/B | -12.8 | -16.7 | · | -18.4 | -20.6 | -23.9 | · | -47.4 | -52.1 | -54.4 | · | -26.7 | -36.0 | -29.2 | · | -15.5 | |
| P / Cash Flow | · | 52.3 | · | · | · | 50.8 | · | · | · | 35.6 | · | · | · | 40.4 | · | · | |
| P / FCF | · | 117.7 | · | · | · | 127.2 | · | · | · | 65.0 | · | · | · | 120.1 | · | · | |
| EV / EBITDA | 135.0 | 154.7 | · | 152.3 | 149.4 | 148.2 | · | 170.5 | 150.6 | 159.4 | · | 136.0 | 158.5 | 146.5 | · | 118.7 | |
| EV / FCF | · | 160.7 | · | · | · | 193.1 | · | · | · | 93.8 | · | · | · | 182.8 | · | · | |
| EV / Revenue | 1.7 | 1.9 | · | 1.8 | 1.8 | 1.8 | · | 2.1 | 1.8 | 1.9 | · | 1.7 | 2.0 | 1.8 | · | 1.5 | |
| Earnings Yield | 7.3% | 5.8% | · | 5.9% | 6.2% | 6.6% | · | 5.0% | 6.1% | 5.7% | · | 6.9% | 5.6% | 6.4% | · | 10.3% | |
| Payout Ratio | · | 11.3% | · | · | · | 11.2% | · | · | · | 11.6% | · | · | · | 12.8% | · | · |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenu | $75.60B | $70.60B | $64.97B | $60.23B | $58.75B |
| Résultat net | $6.78B | $5.76B | $5.24B | $5.64B | $6.96B |
| BPA dilué | $28.33 | $22.00 | $18.97 | $19.15 | $21.16 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dette / Capitaux propres | -6.9 | -17.2 | -22.3 | -13.8 | -37.1 |
| Ratio de liquidité | 1.0 | 1.1 | 1.2 | 1.4 | 1.4 |
| Ratio de liquidité réduite | 0.7 | 0.8 | 0.9 | 1.0 | 1.0 |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $7.69B | $5.64B | $4.69B | $4.13B | $5.38B |
Dernières actualités Actualités récentes mentionnant cette entreprise
- Could HCA Healthcare, Inc. (HCA) Stock Rebound After Guidance Cuts and Payer Pressure?
- Bernstein Remains Bullish On HCA Healthcare (HCA); Projects EBITDA Growth Of 2.8% and 4.6% in 2026 And 2027
- HCA Healthcare (HCA) Reports Q1 2026 Financial Growth With $19.1B in Revenue
- Activité notable sur les options jeudi : HCA, HRTG, ZM
- La stratégie de financement de HCA Healthcare (HCA) s'étend – Voici comment
- HCA Healthcare dépasse les estimations de bénéfices trimestriels grâce à la demande de soins médicaux
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Détenteurs institutionnels (13F) 1 486 déclarants · $39.4B total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 128 (-51 vs T. préc.) | 174 (+70 vs T. préc.) | 450 (-30 vs T. préc.) | 555 (-4 vs T. préc.) | +16.3M |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| VANGUARD GROUP INC | $6 118 113 464 | 13 104 814 | 15,52% | Actions |
| VANGUARD CAPITAL MANAGEMENT LLC | $3 954 150 533 | 10 141 708 | 10,03% | Actions |
| Sanders Capital, LLC | $3 442 060 818 | 8 828 287 | 8,73% | Actions |
| STATE STREET CORP | $2 912 102 056 | 7 469 035 | 7,39% | Actions |
| WELLINGTON MANAGEMENT GROUP LLP | $1 750 298 867 | 4 489 212 | 4,44% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $1 225 259 672 | 3 159 159 | 3,11% | Actions |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1 057 704 509 | 2 712 828 | 2,68% | Actions |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $861 456 107 | 2 209 485 | 2,19% | Actions |
| NORGES BANK | $836 457 140 | 2 145 367 | 2,12% | Actions |
| Capital World Investors | $770 864 224 | 1 977 121 | 1,96% | Actions |
| Capital International Investors | $747 403 041 | 1 916 947 | 1,90% | Actions |
| Crake Asset Management LLP | $449 072 183 | 1 151 792 | 1,14% | Actions |
| Metropolis Capital Ltd | $430 915 307 | 910 564 | 1,09% | Actions |
| Darsana Capital Partners LP | $428 879 000 | 1 100 000 | 1,09% | Actions |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $414 533 777 | 1 063 207 | 1,05% | Actions |
| Life Cycle Investment Partners Ltd | $355 737 196 | 912 404 | 0,90% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $339 685 814 | 871 235 | 0,86% | Actions |
| FMR LLC | $325 199 295 | 834 080 | 0,83% | Actions |
| BARCLAYS PLC | $299 888 573 | 769 162 | 0,76% | Actions |
| LYRICAL ASSET MANAGEMENT LP | $255 015 742 | 654 071 | 0,65% | Actions |
| BlackRock, Inc. | $240 062 291 | 615 718 | 0,61% | Actions |
| ROYAL LONDON ASSET MANAGEMENT LTD | $235 649 908 | 604 401 | 0,60% | Actions |
| National Pension Service | $230 650 346 | 591 578 | 0,59% | Actions |
| NORDEA INVESTMENT MANAGEMENT AB | $230 189 125 | 594 466 | 0,58% | Actions |
| GOLDMAN SACHS GROUP INC | $209 775 669 | 538 038 | 0,53% | Actions |
| Gobi Capital LLC | $195 742 325 | 502 045 | 0,50% | Actions |
| Cryder Capital Partners LLP | $194 561 738 | 499 017 | 0,49% | Actions |
| Swiss National Bank | $172 097 446 | 441 400 | 0,44% | Actions |
| AustralianSuper Pty Ltd | $159 635 782 | 409 438 | 0,41% | Actions |
| Consulta Ltd | $155 956 000 | 400 000 | 0,40% | Actions |
| LEE DANNER & BASS INC | $152 150 679 | 390 240 | 0,39% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $151 472 265 | 388 500 | 0,38% | Option d'achat |
| Mitsubishi UFJ Asset Management Co., Ltd. | $147 943 761 | 379 450 | 0,38% | Actions |
| DIMENSIONAL FUND ADVISORS LP | $139 697 405 | 358 300 | 0,35% | Actions |
| Vanguard Global Advisers, LLC | $136 962 509 | 351 285 | 0,35% | Actions |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $134 838 505 | 288 820 | 0,34% | Actions |
| ALLIANCEBERNSTEIN L.P. | $134 459 788 | 284 126 | 0,34% | Actions |
| Sumitomo Mitsui Trust Group, Inc. | $132 794 974 | 340 596 | 0,34% | Actions |
| TD Asset Management Inc | $131 847 152 | 338 165 | 0,33% | Actions |
| Legal & General Group Plc | $127 805 162 | 327 798 | 0,32% | Actions |
| California Public Employees Retirement System | $124 133 958 | 318 382 | 0,31% | Actions |
| LAZARD ASSET MANAGEMENT LLC | $120 619 879 | 309 369 | 0,31% | Actions |
| JANE STREET GROUP, LLC | $119 540 274 | 306 600 | 0,30% | Option d'achat |
| VANGUARD ASSET MANAGEMENT, Ltd | $116 069 863 | 297 699 | 0,29% | Actions |
| CAPTRUST FINANCIAL ADVISORS | $114 741 071 | 294 291 | 0,29% | Actions |
| ANTIPODES PARTNERS Ltd | $113 045 096 | 289 941 | 0,29% | Actions |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $109 718 328 | 231 845 | 0,28% | Actions |
| CITADEL ADVISORS LLC | $105 660 190 | 271 000 | 0,27% | Option d'achat |
| RHUMBLINE ADVISERS | $97 580 413 | 250 277 | 0,25% | Actions |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $97 026 076 | 248 855 | 0,25% | Actions |
| MACKENZIE FINANCIAL CORP | $93 597 383 | 240 061 | 0,24% | Actions |
| BloombergSen Inc. | $93 160 317 | 238 940 | 0,24% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $92 247 974 | 236 600 | 0,23% | Option de vente |
| Brandywine Global Investment Management, LLC | $89 380 814 | 191 451 | 0,23% | Actions |
| BANK OF AMERICA CORP /DE/ | $89 069 981 | 228 449 | 0,23% | Actions |
| NEUBERGER BERMAN GROUP LLC | $85 926 216 | 220 386 | 0,22% | Actions |
| MILFORD FUNDS LTD | $82 165 029 | 210 739 | 0,21% | Actions |
| Bridgewater Associates, LP | $79 227 208 | 203 204 | 0,20% | Actions |
| Prana Capital Management, LP | $75 552 494 | 193 779 | 0,19% | Actions |
| DANSKE BANK A/S | $73 238 497 | 187 844 | 0,19% | Actions |
| FRANKLIN RESOURCES INC | $70 965 828 | 182 015 | 0,18% | Actions |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $70 445 715 | 180 681 | 0,18% | Actions |
| Quantinno Capital Management LP | $70 407 055 | 180 581 | 0,18% | Actions |
| ARGENT CAPITAL MANAGEMENT LLC | $69 149 681 | 177 357 | 0,18% | Actions |
| Retirement Systems of Alabama | $68 081 812 | 174 618 | 0,17% | Actions |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $66 167 842 | 169 709 | 0,17% | Actions |
| BNP PARIBAS FINANCIAL MARKETS | $64 793 090 | 166 183 | 0,16% | Actions |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $64 665 206 | 165 855 | 0,16% | Actions |
| HSBC HOLDINGS PLC | $64 431 534 | 165 332 | 0,16% | Actions |
| AVIVA PLC | $64 264 789 | 164 828 | 0,16% | Actions |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $64 194 533 | 135 649 | 0,16% | Actions |
| SEB Asset Management AB | $63 257 255 | 162 244 | 0,16% | Actions |
| TODD ASSET MANAGEMENT LLC | $62 567 208 | 160 474 | 0,16% | Actions |
| Swedbank AB | $62 528 998 | 160 376 | 0,16% | Actions |
| W1M Investment Management Ltd | $61 247 490 | 143 647 | 0,16% | Actions |
| HARRIS ASSOCIATES L P | $60 080 879 | 154 097 | 0,15% | Actions |
| Ensign Peak Advisors, Inc | $58 372 381 | 149 715 | 0,15% | Actions |
| NEW YORK STATE COMMON RETIREMENT FUND | $57 747 778 | 148 113 | 0,15% | Actions |
| CITADEL ADVISORS LLC | $57 235 852 | 146 800 | 0,15% | Option de vente |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $57 160 993 | 146 800 | 0,15% | Actions |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $56 512 217 | 144 944 | 0,14% | Actions |
| Pictet Asset Management Holding SA | $52 147 803 | 133 739 | 0,13% | Actions |
| VICTORY CAPITAL MANAGEMENT INC | $50 752 761 | 130 172 | 0,13% | Actions |
| Pentwater Capital Management LP | $50 685 700 | 130 000 | 0,13% | Actions |
| D. E. Shaw & Co., Inc. | $50 554 307 | 129 663 | 0,13% | Actions |
| APG Asset Management N.V. | $50 368 550 | 147 699 | 0,13% | Actions |
| AMF Tjanstepension AB | $50 355 853 | 129 154 | 0,13% | Actions |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $50 349 225 | 129 137 | 0,13% | Actions |
| EQUITABLE TRUST CO | $49 147 974 | 126 056 | 0,12% | Actions |
| ENVESTNET ASSET MANAGEMENT INC | $48 919 124 | 125 469 | 0,12% | Actions |
| CANADA PENSION PLAN INVESTMENT BOARD | $48 197 812 | 123 619 | 0,12% | Actions |
| AMERICAN CENTURY COMPANIES INC | $47 460 140 | 121 727 | 0,12% | Actions |
| OpenArc Corporate Advisory, LLC | $47 210 610 | 121 087 | 0,12% | Actions |
| L1 Capital International Pty Ltd | $46 121 648 | 118 294 | 0,12% | Actions |
| FIRST TRUST ADVISORS LP | $44 251 579 | 113 498 | 0,11% | Actions |
| PFA Pension, Forsikringsaktieselskab | $44 046 098 | 112 971 | 0,11% | Actions |
| United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund | $43 830 264 | 112 417 | 0,11% | Actions |
| EP Wealth Advisors, LLC | $43 287 826 | 111 026 | 0,11% | Actions |
| WOLVERINE TRADING, LLC | $42 597 104 | 101 200 | 0,11% | Option d'achat |
| MERCER GLOBAL ADVISORS INC /ADV | $42 302 070 | 108 497 | 0,11% | Actions |
Initiés de la société 91 initiés · 54 dirigeants · 31 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Samuel N Hazen | CEO | 10 février 2026 F | 64 842 | 0 | 7 | $-21 483 290 |
| O'Boyle Michael P | President & CEO - Parallon | 26 février 2013 A | 21 429 | 0 | 0 | $0 |
| Mike A Marks | EVP and CFO | 7 mai 2026 G | 46 576 | 0 | 0 | $0 |
| Bill B Rutherford | CFO and EVP | 16 février 2024 F | 22 251 | 0 | 0 | $0 |
| Russell K Harms | CFO - Central Group | 17 novembre 2006 D | 0 | 0 | 0 | $0 |
| Robert Samuel Hankins JR | CFO-Outpatient Services Group | 17 novembre 2006 D | 0 | 0 | 0 | $0 |
| Richard J Shallcross | CFO - Western Group | 17 novembre 2006 D | 0 | 0 | 0 | $0 |
| Jeffrey T Crudele | CFO-Eastern Division | 1 juillet 2005 F | 13 865 | 0 | 0 | $0 |
| Erol R Akdamar | Group President | 12 novembre 2024 M | 6 843 | 0 | 0 | $0 |
| Timothy M Mcmanus | Group President | 31 juillet 2024 M | 27 008 | 0 | 0 | $0 |
| Richard A Hammett | Group President | 16 février 2024 F | 17 936 | 0 | 0 | $0 |
| Charles J Hall | Group President | 11 novembre 2022 M | 202 443 | 0 | 0 | $0 |
| Bruce A Moore JR | Group President - Service Line | 11 novembre 2022 S | 30 807 | 0 | 0 | $0 |
| Paul W Rutledge | Group President | 31 décembre 2012 A | 335 657 | 0 | 0 | $0 |
| Beverly B Wallace | President - Parallon | 2 novembre 2011 M | 144 714 | 0 | 0 | $0 |
| Charles Robert Evans | President - Eastern Group | 26 juillet 2006 A | 62 173 | 0 | 0 | $0 |
| Marilyn B Tavenner | President-Outpatient Svcs Grp | 27 octobre 2005 A | 26 154 | 0 | 0 | $0 |
| Greg Roth | President-Ambulatory Surgery | 31 octobre 2004 D | 9 029 | 0 | 0 | $0 |
| Jay Grinney | President-Eastern Group | 7 mai 2004 D | 24 177 | 0 | 0 | $0 |
| Jon M Foster | EVP and COO | 10 février 2026 F | 23 062 | 0 | 0 | $0 |
| Michael R Mcalevey | EVP & Chief Legal & Admin Off. | 13 février 2026 M | 8 853 | 0 | 2 | $-2 747 520 |
| Jennifer Berres | SVP & Chief Human Res. Officer | 11 février 2026 S | 11 993 | 0 | 2 | $-4 126 932 |
| Christopher F. Wyatt | SVP & Controller | 11 février 2026 S | 44 379 | 0 | 1 | $-2 020 000 |
| Erica Rossitto | SVP & Chief Nurse Executive | 10 février 2026 F | 10 407 | 0 | 0 | $0 |
| Michael S. Cuffe | EVP and Chief Clinical Officer | 10 février 2026 F | 32 080 | 0 | 1 | $-747 135 |
| Sammie S Mosier | SVP & Chief Nurse Executive | 13 février 2025 F | 11 113 | 0 | 0 | $0 |
| Kathleen M Whalen | SVP & Chief Ethics Officer | 14 novembre 2024 S | 9 454 | 0 | 0 | $0 |
| Phillip G Billington | SVP-Internal Audit Services | 12 novembre 2024 M | 52 702 | 0 | 0 | $0 |
| Joseph A Sowell III | SVP; Chief Development Officer | 5 août 2024 G | 18 526 | 0 | 0 | $0 |
| Deborah M Reiner | SVP - Mktg. & Communications | 29 juillet 2024 S | 3 510 | 0 | 0 | $0 |
| Kathryn A. Torres | SVP-Payer Contracting & Align. | 25 juillet 2024 S | 17 755 | 0 | 0 | $0 |
| Jeffrey E. Cohen | SVP-Government Relations | 9 mai 2024 S | 5 185 | 0 | 0 | $0 |
| Chad J Wasserman | SVP and CIO | 18 mars 2024 M | 1 576 | 0 | 0 | $0 |
| Martin P. Paslick | SVP and CIO | 12 avril 2023 M | 24 643 | 0 | 0 | $0 |
| Jane D. Englebright | SVP and Chief Nursing Officer | 9 novembre 2021 S | 0 | 0 | 0 | $0 |
| Robert A Waterman | SVP & General Counsel | 5 mai 2021 S | 50 062 | 0 | 0 | $0 |
| William J Morrow | SVP - Finance and Treasurer | 18 février 2021 F | 5 578 | 0 | 0 | $0 |
| Sandra L. Morgan | SVP-Provider Relations | 18 février 2021 F | 10 122 | 0 | 0 | $0 |
| Victor L Campbell | SVP-Government Affairs | 1 mai 2019 A | 194 145 | 0 | 0 | $0 |
| John M Steele | SVP & Chief Human Res. Officer | 25 février 2019 M | 84 157 | 0 | 0 | $0 |
| Milton R Johnson | Chairman | 25 février 2019 M | 881 823 | 0 | 0 | $0 |
| Ravi S. Chari | SVP-Clinical Excellence | 25 février 2018 M | 7 003 | 0 | 0 | $0 |
| Alan R Yuspeh | SVP & Chief Ethics Officer | 25 février 2018 M | 35 546 | 0 | 0 | $0 |
| Joseph N Steakley | SVP-Internal Audit Services | 25 février 2018 M | 65 199 | 0 | 0 | $0 |
| Jana Joustra Davis | SVP - Mktg. & Corp. Affairs | 23 mai 2017 M | 26 378 | 0 | 0 | $0 |
| David Gwin Anderson | SVP - Finance | 7 novembre 2016 M | 110 167 | 0 | 0 | $0 |
| Donald W Stinnett | SVP & Controller | 25 février 2016 A | 51 965 | 0 | 0 | $0 |
| Noel B Williams | SVP and CIO | 16 mai 2012 M | 299 030 | 0 | 0 | $0 |
| Jack O Bovender JR | Chairman | 6 octobre 2009 A | 188 340 | 0 | 0 | $0 |
| Carl V George | SVP - Development | 27 février 2009 M | 13 092 | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Activistes et détenteurs de 5%+ 4 participations
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| Frisco Holding II, Hercules Holding II, Thomas F. Frist, Jr., Thomas F. Frist III, William R. Frist, Patricia F. Elcan | 10 février 2026 | 31,60% | Dépôt initial | — | SEC |
| 22 novembre 2006 | — | Dépôt initial | — | SEC | |
| Merrill Lynch Bank USA | 11 septembre 2006 | — | Dépôt initial | — | SEC |
| Frisco, Inc., Frisco Partners, Thomas F. Frist, Jr., Patricia Champion Frist, Patricia Frist Elcan, William Robert Frist, Thomas F. Frist III, Merrill Lynch Professional Clearing Corp., Merrill Lynch, Pierce, Fenner & Smith Incorporated, Merrill Lynch Financial Markets, Inc., Merrill Lynch International, Merrill Lynch & Co., Inc., Merrill Lynch Trust Company, FSB, Citigroup Inc.*, Bank of America Corporation, NB Holdings Corporation, NationsBanc Montgomery Holdings Corporation, Banc of America Securities LLC | 4 août 2006 | — | Dépôt initial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Détention d'ETF Détenu par 207 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
| Fonds | Poids | Unités | Au | Source |
|---|---|---|---|---|
| IHF · iShares Trust | 4,67% | 141 320 SH | 8 août 2026 | Quotidien |
| BUL · Pacer Funds Trust | 3,91% | 11 437 NS | 30 avril 2026 | N-PORT |
| YALL · Tidal Trust I | 3,61% | 9 261 NS | 31 mai 2026 | N-PORT |
| BWTG · ETF Opportunities Trust | 3,02% | 1 646 NS | 31 mai 2026 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 2,32% | 99 335 SH | 8 août 2026 | Quotidien |
| ABIG · EA Series Trust | 2,00% | 2 938 NS | 29 mai 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 1,99% | 39 985 NS | 30 avril 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,67% | 31 685 SH | 8 août 2026 | Quotidien |
| COWZ · Pacer Funds Trust | 1,64% | 688 264 NS | 30 avril 2026 | N-PORT |
| QQWZ · Pacer Funds Trust | 1,64% | 1 762 NS | 30 avril 2026 | N-PORT |
| FEGE · RBB Fund Trust | 1,46% | 74 706 NS | 31 mai 2026 | N-PORT |
| PWV · Invesco Exchange-Traded Fund Trust | 1,39% | 60 385 SH | 8 août 2026 | Quotidien |
| RPG · Invesco Exchange-Traded Fund Trust | 1,30% | 63 448 SH | 8 août 2026 | Quotidien |
| TMFE · RBB Fund, Inc. | 1,29% | 2 892 NS | 31 mai 2026 | N-PORT |
| AMID · EA Series Trust | 1,23% | 3 402 NS | 29 mai 2026 | N-PORT |
| FCPI · FIDELITY COVINGTON TRUST | 1,15% | 7 180 NS | 30 avril 2026 | N-PORT |
| FMAG · FIDELITY COVINGTON TRUST | 1,12% | 6 544 NS | 30 avril 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 1,12% | 73 639 NS | 30 avril 2026 | N-PORT |
| SRHQ · Elevation Series Trust | 1,10% | 4 883 NS | 30 avril 2026 | N-PORT |
| IYH · iShares Trust | 0,99% | 89 420 SH | 8 août 2026 | Quotidien |
| NEAR · iShares U.S. ETF Trust | 0,99% | 48 109 000 SH | 8 août 2026 | Quotidien |
| CURE · Direxion Shares ETF Trust | 0,98% | 3 122 NS | 30 avril 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,90% | 470 451 SH | 8 août 2026 | Quotidien |
| NFRA · FlexShares Trust | 0,88% | 62 176 NS | 30 avril 2026 | N-PORT |
| REVS · Columbia ETF Trust I | 0,87% | 5 693 NS | 30 avril 2026 | N-PORT |
| RXL · ProShares Trust | 0,86% | 1 632 NS | 31 mai 2026 | N-PORT |
| DIVB · iShares Trust | 0,85% | 36 806 SH | 8 août 2026 | Quotidien |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0,82% | 24 078 000 | 8 août 2026 | Quotidien |
| LSEQ · Harbor ETF Trust | 0,81% | 285 NS | 30 avril 2026 | N-PORT |
| IXJ · iShares Trust | 0,80% | 81 465 SH | 8 août 2026 | Quotidien |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 0,76% | 26 493 000 | 8 août 2026 | Quotidien |
| SPVM · Invesco Exchange-Traded Fund Trust | 0,74% | 2 335 SH | 8 août 2026 | Quotidien |
| FTC · First Trust Exchange-Traded AlphaDE… | 0,73% | 21 329 NS | 30 avril 2026 | N-PORT |
| RFFC · ALPS ETF Trust | 0,68% | 533 NS | 31 mai 2026 | N-PORT |
| QUVU · Hartford Funds Exchange-Traded Trust | 0,68% | 2 698 NS | 30 avril 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0,67% | 12 075 SH | 8 août 2026 | Quotidien |
| VCEB · VANGUARD WORLD FUND | 0,62% | 8 146 000 PA | 8 août 2026 | Quotidien |
| FDMO · FIDELITY COVINGTON TRUST | 0,61% | 11 771 NS | 30 avril 2026 | N-PORT |
| RECS · Columbia ETF Trust I | 0,58% | 72 768 NS | 30 avril 2026 | N-PORT |
| AFLG · First Trust Exchange-Traded Fund VI… | 0,56% | 9 664 NS | 31 mai 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,55% | 11 876 SH | 8 août 2026 | Quotidien |
| VLLU · Harbor ETF Trust | 0,54% | 54 NS | 30 avril 2026 | N-PORT |
| LSVD · ADVISORS' INNER CIRCLE FUND | 0,53% | 7 404 NS | 30 avril 2026 | N-PORT |
| WLDR · Two Roads Shared Trust | 0,51% | 844 NS | 30 avril 2026 | N-PORT |
| VALQ · AMERICAN CENTURY ETF TRUST | 0,50% | 4 620 NS | 31 mai 2026 | N-PORT |
| AKAF · ETF Series Solutions | 0,50% | 39 NS | 31 mai 2026 | N-PORT |
| BSCR · Invesco Exchange-Traded Self-Indexe… | 0,50% | 22 679 000 | 8 août 2026 | Quotidien |
| ROUS · Lattice Strategies Trust | 0,47% | 6 388 NS | 30 avril 2026 | N-PORT |
| VCLT · VANGUARD SCOTTSDALE FUNDS | 0,46% | 54 218 000 PA | 8 août 2026 | Quotidien |
| CGGR · Capital Group Growth ETF | 0,45% | 290 273 NS | 31 mai 2026 | N-PORT |